The Science Behind the Symptoms with Howard Schubiner, MD & Rebecca Kennedy, MD

Association for the Treatment of Neuroplastic Symptoms

Join Howard Schubiner, MD & Rebecca Kennedy, MD, as they dive into the research behind fibromyalgia, migraines, back pain, POTS, and talk to guests who experienced these symptoms.

  1. Mar 11

    The Science Behind the Symptoms: EDS and Hypermobility

    Dr. Howard Schubiner and Dr. Becca Kennedy sit down with Gigi Cockell to discuss her experience living with EDS and hypermobility and the chronic symptoms she experienced. Gigi shares her journey of searching for answers and how learning about neuroplastic symptoms helped her understand the role the brain can play in generating real physical pain and other conditions. Her story offers a hopeful perspective for others with EDS and hypermobility who may feel stuck in ongoing symptoms and are looking for a new way to approach recovery.Fransiska Malfait et al., “Classic Ehlers-Danlos Syndrome,” in GeneReviews®, ed. Margaret P.Adam et al. (University of Washington, Seattle, 1993), http://www.ncbi.nlm.nih.gov/books/NBK1244/.Anne De Paepe and Fransiska Malfait, “The Ehlers–Danlos Syndrome, a Disorder with ManyFaces,” Clinical Genetics 82, no. 1 (2012): 1, https://doi.org/10.1111/j.1399-0004.2012.01858.x.Mark Scheper et al., “The Association between Muscle Strength and Activity Limitations in Patientswith the Hypermobility Type of Ehlers-Danlos Syndrome: The Impact of Proprioception,”Disability and Rehabilitation 39, no. 14 (2017): 1391–97, https://doi.org/10.1080/09638288.2016.1196396.Cortney Gensemer et al., “Hypermobile Ehlers-Danlos Syndromes: Complex Phenotypes, ChallengingDiagnoses, and Poorly Understood Causes,” Developmental Dynamics: An Official Publication of theAmerican Association of Anatomists 250, no. 3 (2021): 318–44, https://doi.org/10.1002/dvdy.220;Sabeeha Malek et al., “The Beighton Score as a Measure of Generalised Joint Hypermobility,”Rheumatology International 41, no. 10 (2021): 1707–16, https://doi.org/10.1007/s00296-021- 04832-4.Able Lawrence, “Benign Joint Hypermobility Syndrome,” Indian Journal of Rheumatology, SoftTissue Rheumatism, vol. 9 (2014): S33–36, https://doi.org/10.1016/j.injr.2014.09.009.Gere Luder et al., “THU0622-HPR Discriminating Conditional and Functional Factors for WomenWith and Without Hypermobility—an Observational Study,” Poster Presentations, Annals of theRheumatic Diseases 74, no. Suppl. 2 (2015): Suppl 2, https://doi.org/10.1136/annrheumdis-2015- eular.1742.Peter R. Reuter and Kaylee R. Fichthorn, “Prevalence of Generalized Joint Hypermobility, MusculoskeletalInjuries, and Chronic Musculoskeletal Pain among American University Students,”PeerJ 7 (2019): e7625, https://doi.org/10.7717/peerj.7625.Leslie N. Russek and Deanna M. Errico, “Prevalence, Injury Rate and, Symptom Frequency inGeneralized Joint Laxity and Joint Hypermobility Syndrome in a ‘Healthy’ College Population,”Clinical Rheumatology 35, no. 4 (2016): 1029–39, https://doi.org/10.1007/s10067-015-2951-9.Darcisio Hortelan Antonio and Claudia Saad Magalhaes, “Survey Joint Hypermobility inUniversity Students Aged 18-25 Years Old,” Advances in Rheumatology 58, no. 1 (2018): 3,https://doi.org/10.1186/s42358- 018- 0008-x.

    1h 9m
  2. Mar 11

    The Science Behind the Symptoms: EDS and Hypermobility

    Dr. Howard Schubiner and Dr. Becca Kennedy sit down with Gigi Cockell to discuss her experience living with EDS and hypermobility and the chronic symptoms she experienced. Gigi shares her journey of searching for answers and how learning about neuroplastic symptoms helped her understand the role the brain can play in generating real physical pain and other conditions. Her story offers a hopeful perspective for others with EDS and hypermobility who may feel stuck in ongoing symptoms and are looking for a new way to approach recovery. Fransiska Malfait et al., “Classic Ehlers-Danlos Syndrome,” in GeneReviews®, ed. Margaret P. Adam et al. (University of Washington, Seattle, 1993), http://www.ncbi.nlm.nih.gov/books /NBK1244/. Anne De Paepe and Fransiska Malfait, “The Ehlers–Danlos Syndrome, a Disorder with Many Faces,” Clinical Genetics 82, no. 1 (2012): 1, https://doi.org/10.1111/j.1399-0004.2012.01858.x. Mark Scheper et al., “The Association between Muscle Strength and Activity Limitations in Patients with the Hypermobility Type of Ehlers-Danlos Syndrome: The Impact of Proprioception,” Disability and Rehabilitation 39, no. 14 (2017): 1391–97, https://doi.org/10.1080/09638288 .2016.1196396. Cortney Gensemer et al., “Hypermobile Ehlers-Danlos Syndromes: Complex Phenotypes, Challenging Diagnoses, and Poorly Understood Causes,” Developmental Dynamics: An Official Publication of the American Association of Anatomists 250, no. 3 (2021): 318–44, https://doi.org/10 .1002/dvdy.220; Sabeeha Malek et al., “The Beighton Score as a Measure of Generalised Joint Hypermobility,” Rheumatology International 41, no. 10 (2021): 1707–16, https://doi.org/10.1007/s00296-021 - 04832-4. Able Lawrence, “Benign Joint Hypermobility Syndrome,” Indian Journal of Rheumatology, Soft Tissue Rheumatism, vol. 9 (2014): S33–36, https://doi.org/10.1016/j.injr.2014.09.009. Gere Luder et al., “THU0622-HPR Discriminating Conditional and Functional Factors for Women With and Without Hypermobility—an Observational Study,” Poster Presentations, Annals of the Rheumatic Diseases 74, no. Suppl. 2 (2015): Suppl 2, https://doi.org/10.1136/annrheumdis-2015 - eular.1742. Peter R. Reuter and Kaylee R. Fichthorn, “Prevalence of Generalized Joint Hypermobility, Musculoskeletal Injuries, and Chronic Musculoskeletal Pain among American University Students,” PeerJ 7 (2019): e7625, https://doi.org/10.7717/peerj.7625. Leslie N. Russek and Deanna M. Errico, “Prevalence, Injury Rate and, Symptom Frequency in Generalized Joint Laxity and Joint Hypermobility Syndrome in a ‘Healthy’ College Population,” Clinical Rheumatology 35, no. 4 (2016): 1029–39, https://doi.org/10.1007/s10067-015-2951-9. Darcisio Hortelan Antonio and Claudia Saad Magalhaes, “Survey Joint Hypermobility in University Students Aged 18-25 Years Old,” Advances in Rheumatology 58, no. 1 (2018): 3, https://doi.org/10.1186/s42358- 018- 0008-x.

    1h 9m
  3. The Science Behind the Symptoms: Epstein–Barr, Chronic Fatigue/Myalgic Encephalomyelitis

    Jan 28

    The Science Behind the Symptoms: Epstein–Barr, Chronic Fatigue/Myalgic Encephalomyelitis

    In this episode, Dr. Howard Schubiner and Dr. Becca Kennedy unpack the science behind Rebecca Tolin’s recovery from 13 years of chronic fatigue syndrome/myalgic encephalitis. Although she was told that Epstein–Barr virus (among many other diagnoses) was the reason for her CFS/ME, she actually recovered through neuroplastic recovery therapies. Dr. Schubiner and Dr. Kennedy describe the scientific studies that break down why EBV is not a valid explanation for persistent symptoms. Together, they illustrate how Rebecca fully healed by addressing the learned patterns in her brain—and what her story reveals about the true mechanisms behind many chronic symptoms.🛜 Visit our website www.symptomatic.me🧑‍💻 Experiencing chronic pain or illness?Learn more from the 12-Question Self Assessment. https://www.symptomatic.me/quiz🧠 Knowledge becomes healingExplore common conditions: https://www.symptomatic.me/commonconditions📚 Start your recoveryFree public resources: https://www.symptomatic.me/treatment-plan🧑‍⚕️ For practitioners and studentsClinical tools and guidance: https://www.symptomatic.me/learningprogram🎤 Share your storyBe featured on the podcast: https://form.jotform.com/243224080632043👩🏻‍🏫 Advantages of Membership in theATNS Community: https://www.symptomatic.me/membership💵 Support the missionDonate to expand awareness: https://givebutter.com/XJtTyC💡About ATNSThe Association for the Treatment of Neuroplastic Symptoms is a 501(c)(3) nonprofit advancing the science of chronic pain and illness. Led by volunteer clinicians, researchers, and advocates, ATNS provides education, tools, and support for the diagnosis and treatment of neuroplastic conditions. We bridge research with real-world care—helping people reclaim their lives.

    40 min
4.9
out of 5
25 Ratings

About

Join Howard Schubiner, MD & Rebecca Kennedy, MD, as they dive into the research behind fibromyalgia, migraines, back pain, POTS, and talk to guests who experienced these symptoms.

You Might Also Like